Novo Nordisk is expected to report third-quarter earnings on Wednesday. Stock up 8.55% in a year, 7.45% year-to-date.

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

It’s possible for lean mass loss to happen with other weight loss strategies too. These include calorie restriction and ...

Smoothie King has now added menu items the company says pair well with diet drugs. The company says users of GLP-1 weight ...

Compounded GLP-1s for Weight Loss: What Are They and Are They Safe? GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains ... treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered.

A consortium of medical groups are now recommending that most patients who are taking a GLP-1 weight-loss or diabetes drugs ...

Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with greater weight loss than bariatric surgery alone, suggested an ...

Smoothie King says it is the first quick service restaurant brand with a GLP-1 focused menu.